Jason A. Kahn joined OrbiMed in 1999 as an Equity Trader. Mr. Kahn was previously a research associate at National Securities Corporation and Dirks & Company. From 1993 to 1997, he worked as a research scientist in immunology and gene therapy at New York University, Cornell University and the University of Wisconsin-Madison. Mr. Kahn received his B.S. in Zoology from the University of Wisconsin-Madison.